2010年5月20日 · In this randomized trial involving patients who were physically ineligible for open repair, endovascular repair of abdominal aortic aneurysm was associated with a significantly lower rate of...

2023年6月22日 · Endovascular aneurysm repair (EVAR) is an important advance in the treatment of abdominal aortic aneurysm (AAA). EVAR is performed by inserting graft components that are folded and compressed within a delivery sheath through the lumen of an access vessel, usually the common femoral artery.

The EVAR trial 2 patients and their follow-up Between 1 September 1999 and 31 August 2004, 404 patients were recruited to participate in EVAR-2. A total of 197 patients were randomly assigned to the endovascular group and 207 were assigned to the no-intervention group.

The endovascular aneurysm repair-2 (EVAR-2) trial suggested that EVAR in patients unfit for open surgical repair (OSR) failed to provide a significant overall survival advantage compared with conservative management.

We instigated EVAR trial 2 to identify whether EVAR improves survival compared with no intervention in patients unfit for open repair of aortic aneurysm. Methods: We did a randomised controlled trial of 338 patients aged 60 years or older who had aneurysms of at least 5.5 cm in diameter and who had been referred to one of 31 hospitals in the UK.

2013年6月23日 · The purpose of the EVAR II trial was to assess the benefits and risks associated with endovascular aortic aneurysm repair in patients who were unfit for the open procedure.

EVAR-2 randomised patients who were considered to be unfit to undergo OR to EVAR or no intervention. The two EVAR trials are now well placed to compare the long-term durability of EVAR up to 15 years.

Summary background data: EVAR-2 remains the sole randomized trial to identify whether EVAR reduces mortality in patients physically ineligible for open repair.

2010年1月1日 · Endovascular repair of abdominal aortic aneurysm would be associated with lower operative and long-term mortality. Patients with an abdominal aortic aneurysm were randomized to endovascular repair (n = 197) versus medical management (n = 207). Overall, 404 patients were enrolled.

We instigated EVAR trial 2 to identify whether EVAR improves survival compared with no intervention in patients unfit for open repair of aortic aneurysm. We did a randomised controlled trial of 338 patients aged 60 years or older who had aneurysms of at least 5·5 cm in diameter and who had been referred to one of 31 hospitals in the UK.